⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ESALY News
New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment USA - English USA - English
prnewswire.com
ESALY
BIVVF
New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment USA - English USA - English
prnewswire.com
ESALY
BGNE